HomeAXSM • NASDAQ
add
Axsome Therapeutics Inc
Previous close
$127.54
Day range
$125.92 - $130.11
Year range
$64.11 - $139.13
Market cap
6.16B USD
Avg Volume
1.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 118.77M | 66.04% |
Operating expense | 169.88M | 42.50% |
Net income | -74.91M | 24.06% |
Net profit margin | -63.08 | 54.26% |
Earnings per share | -1.54 | 25.96% |
EBITDA | -59.56M | -11.69% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 315.35M | -18.34% |
Total assets | 568.50M | -3.36% |
Total liabilities | 511.48M | 28.75% |
Total equity | 57.02M | — |
Shares outstanding | 48.77M | — |
Price to book | 109.01 | — |
Return on assets | -27.27% | — |
Return on capital | -57.58% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -74.91M | 24.06% |
Cash from operations | -26.20M | 13.70% |
Cash from investing | -30.00K | -328.57% |
Cash from financing | 14.24M | 712,300.00% |
Net change in cash | -11.99M | 60.53% |
Free cash flow | 464.75K | 103.50% |
About
Founded
2012
Website
Employees
683